Journal of Clinical Immunology

, Volume 38, Issue 3, pp 257–259 | Cite as

Francisella philomiragia: Think of Chronic Granulomatous Disease

  • Angel Robles-Marhuenda
  • Marco Vaca
  • Pilar Romero
  • Antonio Ferreira
  • Eduardo López-Granados
  • Francisco Arnalich
Letter to Editor
A 20-year-old man was referred to our department with fever (about 38 °C), odynophagia, and dry cough for 2 weeks. He has a history of chronic granulomatous disease (CGD) linked X, diagnosed 18 months of birth, and he received primary prophylaxis with trimethoprim-sulfamethoxazole and itraconazole since. He had maternal uncle affection, being his mother the carrier of the mutation. He denied sore throat, neck pain, hoarseness, stridor, dyspnea, chest pain, arthralgia, or weight loss. He returned from recently holidays in Mediterranean beach. The examination revealed hyperemic pharynx, mild tonsillar hypertrophy, submandibular lymph nodes of 2 cm diameter and 1 cm at neck, mobile and not painful. Respiratory and systemic examination was normal. In the chest radiograph, a pulmonary nodule 2 cm in the right lower lobe was evident. Amoxicillin and clarithromycin were prescribed, but the fever and cough were not solved. A CT scan showed a nodular diffuse bilateral pattern more prevalent in...


Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.


  1. 1.
    Hollis DG, Steigerwalt AG, Wenger JD, Moss CW, Brenner DJ. Francisella philomiragia comb. Nov. (formerly Yersinia philomiragia) and Francisella tularensis biogroup novicida (formerly Francisella novicida) associated with human disease. J Clin Microbiol. 1989;27:1601–8.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Wenger JD, Hollis DG, Weaver RE, Baker CN, Brown GR, Brenner DJ, et al. Infection caused by Francisella philomiragia (formerly Yersinia philomiragia). A newly recognized human pathogen. Ann Intern Med. 1989;110:888–92.CrossRefPubMedGoogle Scholar
  3. 3.
    Sicherer SH, Asturias EJ, Winkelstein JA, Dick JD, Willoughby RE. Francisella philomiragia sepsis in chronic granulomatous disease. Pediatr Infect Dis J. 1997;16:420–2.CrossRefPubMedGoogle Scholar
  4. 4.
    Polack FP, Harrington SM, Winkelstein JA, Merz WG, Willoughby RE. Recurrent Francisella philomiragia sepsis in chronic granulomatous disease. Pediatr Infect Dis J. 1998;17:442–3.CrossRefPubMedGoogle Scholar
  5. 5.
    Mailman TL, Schmidt MH. Francisella philomiragia adenitis and pulmonary nodules in a child with chronic granulomatous disease. Can J Infect Dis Med Microbiol. 2005;16:245–8.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Friis-Møller A, Lemming LE, Valerius NH, Bruun B. Problems in identification of Francisella philomiragia associated with fatal bacteremia in a patient with chronic granulomatous disease. J Clin Microbiol. 2004;42:1840–2.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Zeytun A, Malfatti SA, Vergez LM, Shin M, Garcia E, Chain PSG. Complete genome sequence of Francisella philomiragia ATCC 25017. J Bacteriology. 2012;194:3266.CrossRefGoogle Scholar
  8. 8.
    Mikalsen J, Olsen AB, Tengs T, Colquhoun DJ. Francisella philomiragia subsp. Noatunensis subsp. nov., isolated from farmed Atlantic cod (Gadus morhua L.). Int J Syst Evol Microbiol. 2007;57:1960–5.CrossRefPubMedGoogle Scholar
  9. 9.
    Geier H, Celli J. Phagocytic receptors dictate Phagosomal escape and intracellular proliferation of Francisella tularensis. Infect Immun. 2011;79:2204–14.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Internal Medicine DepartmentLa Paz Universitary HospitalMadridSpain
  2. 2.Microbiology DepartmentLa Paz Universitary HospitalMadridSpain
  3. 3.Immunology DepartmentLa Paz Universitary HospitalMadridSpain

Personalised recommendations